Health Economics and Health Technology Assessment: Perspectives from Australia and New Zealand

摘要

Formal health economics and health technology assessment (HTA) processes, including cost-effectiveness and cost-utility analysis, are variably used to inform decisions about public and private health service funding and service provision. In general, Pharmaceuticals have been subject to more sophisticated health economic analyses and HTAs and for a longer time than either devices or procedures. HTA has been performed by a number of different entities including agencies located within various government departments, private sector agencies, and academic and professional groups. While HTA shares many common features across the world, its uses, approaches, applications, and impact differ throughout the world.